| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K10-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-742
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-00 |
| filingDate |
2003-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006501311-A |
| titleOfInvention |
Compositions and methods for inhibiting pathogenic growth |
| abstract |
The present invention includes methods and compositions for treating animals to control the incidence and growth of E. coli O157: H7 and other pathogens. The method of treatment involves providing the animal with a therapeutically effective amount of one or a combination of Lactobacillus acidophilus or many other functional bacteria. An alternative method of treatment involves administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus acidophilus in combination with a lactate-utilizing bacterium such as Propionibacterium freudenreichii. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016522810-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5933260-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010119874-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102262466-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014014355-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014000026-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016216408-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012034616-A |
| priorityDate |
2002-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |